A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
Saved in:
| Title: | A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. |
|---|---|
| Authors: | Sebastian, Martin1,2 (AUTHOR) martin.sebastian@kgu.de, Schröder, Andreas3,4 (AUTHOR), Scheel, Birgit3 (AUTHOR), Hong, Henoch S.3,4 (AUTHOR), Muth, Anke3 (AUTHOR), von Boehmer, Lotta5,6 (AUTHOR), Zippelius, Alfred7 (AUTHOR), Mayer, Frank8,9 (AUTHOR), Reck, Martin10 (AUTHOR), Atanackovic, Djordje11,12 (AUTHOR), Thomas, Michael13 (AUTHOR), Schneller, Folker14 (AUTHOR), Stöhlmacher, Jan15,16 (AUTHOR), Bernhard, Helga17 (AUTHOR), Gröschel, Andreas18,19 (AUTHOR), Lander, Thomas3 (AUTHOR), Probst, Jochen3,20 (AUTHOR), Strack, Tanja3 (AUTHOR), Wiegand, Volker3 (AUTHOR), Gnad-Vogt, Ulrike3 (AUTHOR) |
| Source: | Cancer Immunology, Immunotherapy. May2019, Vol. 68 Issue 5, p799-812. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
